chrisvoncsefalvay/vaers-outcomes huggingface dataset:
When leaving walking in parking lot very dizzy felt like I was drunk ( I do not drink at all) same when I got home.  Slept 2 days, woke up  little wheezing, BAD headache....lasted 3days . Next day I had bad muscle pain, some bone pain, arm sore that wasn?t bothersome. EXTREME FATIGUE .....couldn?t get off couch  bout 8 days. When I did very dizzy would stagger to the right. Fell into other couch trying to get up bout the 3 day. Fatigue was getting worse, hard to move body, VERY SLEEPY . Family insisted I go to ER or they would call EMS. I only will go if on death bed. This was 1st time in life I waited 8 days to shower, I?m a very clean person, I will even do my makeup almost daily. My biggest concern is the MALAISE AND FATIGUE WAS WORSENING AS DAYS WENT ON.   I DO HAve Hx. Of reactions to tetanus but nothing like this. I?m waiting to go to dr to have labs drawn because of this. Thanks you
significant swelling (may be tennis ball size) in my shoulder area; lymph node, but seemed furtherdown my neck than that. It wastender to touch and sore; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the left arm on 17Mar2021, at 10:30 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medication within two weeks of vaccination included trinessa (MANUFACTURER UNKNOWN) and claritin (MANUFACTURER UNKNOWN), both for unknown indication from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021, at 18:00, the patient had significant swelling (maybe tennis ball size) in her shoulder area on the side of the vaccination. It was reported that maybe a lymph node, but seemed further down her neck than that which was tender to touch and sore. Therapeutics measures included iced the area for events swelling arm and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of swelling arm and swollen lymph nodes was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Itching at injection spot followed by swelling  and warm to touch.  Each day it spread from my elbow to shoulder with a rash that was very itchy. I?m still itching 10 days later.
PATEINT RECEIVED VACCINE AND THEN ABOUT 15 MINUTES LATER WE WERE TOLD BY COWORKERS SHE WAS FEELING FAINT.  I CAME OVER TO CHECK ON HER AND SHE WAS COUGHING LIGHTLY AND SITTING DOWN WITH SOME WATER.  I ASKED HER IF HER THROAT FELT TIGHT OR HER CHEST FELT TIGHT AND SHE REPLIED THAT IT REALLY JUST FELT LIKE A TICKLE.  I TOLD HER IF SHE IS HAVING ANY SYMPTOMS LIKE THIS IT IS SERIOUS AND I NEED TO GIVE HER AN EPIPEN SHOT AND CALL 911 FOR HER.  SHE RESPONDED THAT SHE REALLY DID NOT FEEL THAT BAD AND THAT IT WAS MORE LIKE A TICKLE.  I GAVE HER 50 MG ORAL BENADRYL BECAUSE SHE REFUSED AN EPIPEN. I HAD HER REMAIN SEATED FOR 15-20 MINUTES AND THEN SHE GOT BACK UP AND WENT BACK TO HER JOB.  I SAT AT THE COUNTER IN THE BUILDING AND TOLD HER I WAS GOING TO STAY WITH HER UNTIL HER SHIFT WAS OVER.  HER SHIFT ENDED AT 3:45 AND SHE SAID SHE FELT FINE AND SHE LOOKED FULLY HEALTHY.  I TOLD HER THAT IF SHE HAD ANY OTHER SYMPTOMS LIKE COUGHING THAT SHE MUST GO STRAIGHT TO THE ER NO MATTER WHAT!
Patient 10yo, given PFIZER 12+ and up formulation.  Parent called and notified, patient having no symptoms or side effects, educated parent on warning signs/symptoms to look for and notify facility if they develop.
bilateral ascending tingling, numbness, fasciculations, muscle spasms, cramping, sharp pain ascending from feet to face.
I felt nauseated; I experienced a severe headache the following day.; 1 dose start date 18Dec2020; 2 dose start date 07Jan2021; 1 dose start date 18Dec2020; 2 dose start date 07Jan2021; This is a spontaneous report from a contactable other health professional (patient). A 47-year-old female patient (pregnant: No) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number/expiration date unknown) via intramuscular on 07Jan2021 02:45 PM (vaccine location: Right arm) at a single dose for COVID-19 immunization. Previous vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number/expiration date unknown) via intramuscular on 18Dec2020 02:30 PM (vaccine location: Right arm) at a single dose for COVID-19 immunization. Medical history were not reported. The concomitant included Multi-vitamin, 2 naproxen sodium (ALEVE) the day of the 2nd dose of the vaccine (07Jan2021). No other vaccine in four weeks. Patient experienced a severe headache the following day (08Jan2021). On Saturday, 09Jan2021 patient felt nauseated. No treatment given for severe headache and nauseated. The outcome of the events, severe headache and nauseated was recovered in Jan2021.   Information on lot/batch number has been requested.
Pt Chief Complaint is body aches, chills, fever, nausea, and general flulike symptoms.
has superfical vein thrombus spanning 5 cm in that particular arm; This is a spontaneous report from a Pfizer-sponsored program. A contactable physician reported for female consumer (Patient) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), via an unspecified route of administration in left deltoid on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. on an unspecified date the physician reported that a young lady experienced who received COVID-19 pfizer vaccine in left deltoid muscle and has superficial vein thrombus spanning 5 cm in that particular arm. Physician further questioned that any one reported cases of superficial vein thrombus at the site of injection. The outcome of the event was unknown. The lot number for the vaccine, [bnt162b2], was not provided and will be requested during follow up.
HIVES AN HOUR AFTER ADMINISTRATION OF MENACTRA AND TENIVAC.
"Pfizer-Bio-Tech COVID-19 Vaccine EUA" Individual received  1 st dose of Pfizer vaccine 1 1/2 months before 12 th birthday. Mother was notified and agreed to bring child for second vaccine after his 12th birthday.
Bleeding after injection; A spontaneous report  was received from a Consumer concerning a 89 Years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced bleeding after injection.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced bleeding after injection.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of event was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient is also feeling extremely tired; Muscle aches; Pains; Low red blood cell count; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of red blood cell count decreased (received 1st dose in August 2019 and experienced red bllod count decreased, feeling extremely tired, with muscle aches and pains, refer case US2019202816).   On 23rd October 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced tiredness, muscle pain, pain and red blood cell count decreased. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the tiredness, muscle pain, pain and red blood cell count decreased were recovering/resolving.   It was unknown if the reporter considered the tiredness, muscle pain, pain and red blood cell count decreased to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's wife. The reporter stated that the patient red blood cell count was lower than it should be, and also felt extremely tired, with muscle aches and pain. The endocrinologist recommended the patient to the hematologist because the blood cell count was low enough that it merits an hematologist. The reporter stated that the patient thinks the red blood cell count was around 110,000. This case has been linked with cases US2019202829 and US2019202816 reported by the same reporter.      Lab Comments: lab test done on unknown date
The illness started the next day, this was draining. I eventually conquered thre illness and headaches by the following week. The irregularities in my monthly cycle flow began on 11/22/2021 (4 days after shot). I did research prior to the shot, I learned all 3 vaccines had reviews with women reporting this irregularalirity. However this is mandated at my job. My monthly cycles have truly been altered and this concerns me. My body wasn't receptive. My monthly flow now has clots, its more lengthy, and the flow is heavier. The clots have gotten smaller since this started but I'm praying my body will revert back to my normal flow naturally. I'm currently looking for a new doctor  (wasn't ensured in the beginning of these adverse events), to discuss further.
I was about 4 weeks and 3 days pregnant when I received my second dose of the vaccine.  Everything seemed fine. The next day I woke up and I no longer "felt pregnant", but it was my first pregnancy so I did not think too much of it. Thursday I started having spotting and asked my doctor to do another BETA to see if my HCG levels were ok. That night I got the call that my levels had dropped and that I was losing the baby. I started heavily bleeding the next day. I have also had extreme back and muscle pain after each dose.
extremely dry mouth; Vomit one time; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (extremely dry mouth) and VOMITING (Vomit one time) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VOMITING (Vomit one time). On an unknown date, the patient experienced DRY MOUTH (extremely dry mouth). At the time of the report, DRY MOUTH (extremely dry mouth) outcome was unknown and VOMITING (Vomit one time) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient reported using Biotin mouth rinse for treatment of dry mouth.   Reporter did not allow further contact
Initial solicited report received on 04 August 2015 from a partner performing market research for Sanofi Pasteur for the below mentioned study. This case involves a female child subject (date of birth or age not reported) who developed a reaction to the last dose administered during the study participation. The subject's medical history and concomitant therapies were not reported. On an unknown date, after receiving a dose Meningococcal A-C-Y-W135 vaccine on an unspecified date (batch number, route and site of administration not reported), the subject developed a reaction. It was reported that the subject would not receive the booster vaccine as she had a reaction to the last dose administered. The subject's lab investigations and corrective treatment were not reported. Outcome of the event was unknown. Relationship to investigational product according to company: not associated. Relationship to investigational product according to reporter: not reported. It was not reported if the event led to the termination of the subject. List of documents held by sender: none.
minister of received 1st dose with AstraZeneca and 2nd dose with Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (minister of  received 1st dose with AstraZeneca and 2nd dose with Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Prime minister of Germany received 1st dose with AstraZeneca and 2nd dose with Moderna vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Prime minister of Germany received 1st dose with AstraZeneca and 2nd dose with Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment and concomitant medications were provided
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: fainted on 2 separate occasions and vomited-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Systemic: Vomiting-Mild, Additional Details: called 911 and she was taken to hospital by ambulance
Within a few minutes of getting the injection my face began tingling.  A few minutes after that the tingling turned into a burning feeling.  My cheeks were slightly flushed but felt like I had a bad sunburn.  At the same time my throat felt thick.  I could talk and breathe but it definitely felt like it had swelled inside my throat.  I also felt shaky.  My hands were not shaky but I felt shaky on the inside.  I didn't report this to the people working the vaccine clinic (but in retrospect I should have) The thick throat feeling resolved within one hour and the face burning feeling was gone by the next morning.  Then I just had the typical sore arm, a few body aches and nothing else. Note: never a vaccine reaction but I had an anaphylactic reaction requiring treatment when receiving a 2nd dose of chemotherapy
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with (Oka-Merck) PROQUAD, (lot number reported as J002932) Dose, route, and expiration date were not reported. No co-suspect and concomitant therapies were reported. The nurse reported that the patient was administered (Oka-Merck) PROQUAD that was stored improperly (on an unknown date). No adverse effects reported. The outcome and causality of the events was not reported. This is one of four reports from the same source (other cases # 1407USA000488, #1406USA011997 and #1407USA005742). Additional information has been requested.
Itching, hives under arms spreading over whole body; shortness of breath.  Seen @ ER.  Treated with prednisone, Benadryl, Zantac in ER. Has Rx for prednisone 20 mg #18; Zantac 150 mg bidx7 days, Benadryl 25 mg q 6hrs prn.
Patient's arm swelled; warm; kind of red.; firm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Patient's arm swelled), FEELING HOT (warm), ERYTHEMA (kind of red.) and MUSCLE RIGIDITY (firm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     Concomitant products included METFORMIN, AMLODIPINE, ASCORBIC ACID, ASPIRIN [ACETYLSALICYLIC ACID], BILBERRY [VACCINIUM MYRTILLUS], ENALAPRIL, GABAPENTIN, GINKGO BILOBA (GINGKO BILOBA), GLUCOSAMINE, HYDROCHLOROTHIAZIDE, SALMON OIL, METOPROLOL, SIMVASTATIN and LIPO FLAVONOID PLUS for an unknown indication.    On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Patient's arm swelled), FEELING HOT (warm), ERYTHEMA (kind of red.) and MUSCLE RIGIDITY (firm). At the time of the report, PERIPHERAL SWELLING (Patient's arm swelled), FEELING HOT (warm), ERYTHEMA (kind of red.) and MUSCLE RIGIDITY (firm) outcome was unknown.            No treatment medication was reported. Patient had Moderna for the 1st and 2nd dose and did not have any reaction.
Passed out; Dizzy; Sweating; Pain in arm; aches; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Iodine allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced LOSS OF CONSCIOUSNESS (Passed out) (seriousness criterion medically significant). 15-May-2021, the patient experienced DIZZINESS (Dizzy), HYPERHIDROSIS (Sweating), VACCINATION SITE PAIN (Pain in arm), MYALGIA (aches), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 17-May-2021, LOSS OF CONSCIOUSNESS (Passed out), DIZZINESS (Dizzy), HYPERHIDROSIS (Sweating), VACCINATION SITE PAIN (Pain in arm), MYALGIA (aches), CHILLS (Chills) and FATIGUE (Fatigue) had resolved. Not Provided.        Concomitant medication use was not provided. Action taken with mRNA-1273 in response to the event was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-083017 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
I experienced dizziness, weird noise in my ears, brain fog, and neck pain. I also had shooting pains in my chest, heart palpitations, extreme nausea, cramps after eating. I experienced severe pain in my right side and upper abdominal pain. My liver felt like I was carrying a baby because it was so enlarged. I had severe calf cramps and I felt like I was having a gallbladder attack but I don't have a gallbladder. I ended up having a blood clot in my lung. I had herniated disc in my neck and it exacerbated the pain was way worse than it has ever been. I am on an inhaler for continuous of shortness of breath. I was diagnosed with segmental atelectasis in my lungs which I never had before. I am still suffering with gastritis and taking medication for that. I had 3 ER visits at the Hospital for these issues.
Pt has a history of COPD, but not oxygen dependent at home.  He also has diabetes.  He arrived to the ED due to shortness of breath, myalgias, fever, and cough.  He was admitted for acute hypoxic respiratory failure due to COVID-19 and elevated troponin.
Nurse administered hepatitis A intra-nasal when should have been given intra-muscular.  The patient was to receive a flu mist vaccine that is given intra-nasal.
Test positive for covid=10; Test positive for covid=10; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old male patient received BNT162b2 (BNT162B2), on 02Jun2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 24Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 04Apr2022 as dose 4 (booster), single (Lot number: 2895) at the age of 79 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), on 27Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Heart disease" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing); "Pacemaker" (unspecified if ongoing); "Heart valve replacement" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Test positive for covid=10". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Test positive for covid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: anti viral treatment was received for the events from 23Aug2022 to 27Aug2022. Patient had no known allergies   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Mentally challenged 16 y/o was administered Moderna vaccine which is not labeled for use in patients under the age of 18.
Information has been received from a 56 year old female with a history of pneumonia and no drug allergies, who on 02-JUL-2007 was vaccinated with a single dose of PNEUMOVAX 23.  Concomitant therapy included prednisone.  On 03-JUL-2007 the patient developed redness, warmth, rash, and tenderness at the injection site.  The patient also reported that she experienced nausea and by 06-JUL-2007 the rash went down to her elbow and she felt achy and had a fever.  The patient reported that the rash was clearing up, but at the injection site it felt like there was a knot underneath the skin.  The patient sought unspecified medical attention.  No laboratory diagnostic studies were performed.  At the time of the report, the patient was recovering.  No product quality complaint was involved.  Additional information is not expected.
The doctor suggested I should get a pneumococcal conjugate vaccine because I am over 65. I never had this vaccine.
The patient was inadvertently given a 3rd booster of the Moderna Covid-19 vaccine. Patient has not experienced any adverse events to date. Patient continues to be monitored regularly for any side effects from receipt of the extra booster dose. 2nd booster dose was administered on 05/25/2022.
Previously healthy 13yo female admitted on 7/11/21 with headache (initially started 6/27, intermittent but progressed), left-sided weakness, brief syncopal episode and altered mental status and hallucinations. Developed orofacial dyskinesias and choreoathetoid movements. CSF with WBC of 359 (73% lymphs, 23% monos), negative infectious workup but positive Anti-NMDA antibodies, ultimately diagnosed with anti-NMDA autoimmune encephalitis.  The patient has received the following treatments for her autoimmune encephalitis: * IVIG 7/12-7/16  * Methylprednisolone 1000mg IV daily 7/12-7/17   * Prednisolone 51mg BID 7/18 - 7/22 PO  * Methylprednisolone IV      ? 50mg IV BID 7/23-7/25      ? 40mg BID 7/26 - 8/2      ? 30mg BID 8/2  * Rituximab 600mg 7/23  * PLEX 8/2 - 8/4 (today)  Despite the above interventions, there has been no improvement in the patient's neuropsychiatric status. She is currently intubated with evidence of autonomic instability (suspected secondary to her autoimmune encephalitis), but even prior to recent intubated a few days ago, she does not recognize family members.
Vesicular rash on buttocks, trunk, extremities consistent with varicella-active infection